107 related articles for article (PubMed ID: 8845832)
1. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant.
Watanabe Y; Koizumi K; Zama Y; Kiriyama M; Matsumoto Y; Matsumoto M
Biol Pharm Bull; 1995 Sep; 18(9):1308-10. PubMed ID: 8845832
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
[TBL] [Abstract][Full Text] [Related]
3. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
[TBL] [Abstract][Full Text] [Related]
4. Studies on the development of rapidly disintegrating hyoscine butylbromide tablets.
Khattab IS; Zaghloul1 AA; Afouna MI
Drug Discov Ther; 2007 Aug; 1(1):61-4. PubMed ID: 22504365
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different fast melting disintegrants by means of a central composite design.
Di Martino P; Martelli S; Wehrlé P
Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
[TBL] [Abstract][Full Text] [Related]
7. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.
Shimizu T; Sugaya M; Nakano Y; Izutsu D; Mizukami Y; Okochi K; Tabata T; Hamaguchi N; Igari Y
Chem Pharm Bull (Tokyo); 2003 Oct; 51(10):1121-7. PubMed ID: 14519914
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
Sano S; Iwao Y; Noguchi S; Kimura S; Itai S
Int J Pharm; 2013 May; 448(1):132-41. PubMed ID: 23524122
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules.
Ishikawa T; Koizumi N; Mukai B; Utoguchi N; Fujii M; Matsumoto M; Endo H; Shirotake S; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):230-2. PubMed ID: 11217114
[TBL] [Abstract][Full Text] [Related]
10. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
11. Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation.
Kawashima Y; Takeuchi H; Hino T; Niwa T; Lin TL; Sekigawa F; Kawahara K
Pharm Res; 1993 Mar; 10(3):351-5. PubMed ID: 8464806
[TBL] [Abstract][Full Text] [Related]
12. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose.
Sugimoto M; Maejima T; Narisawa S; Matsubara K; Yoshino H
Int J Pharm; 2005 May; 296(1-2):64-72. PubMed ID: 15885456
[TBL] [Abstract][Full Text] [Related]
14. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
[TBL] [Abstract][Full Text] [Related]
15. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
[TBL] [Abstract][Full Text] [Related]
16. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):175-80. PubMed ID: 16462059
[TBL] [Abstract][Full Text] [Related]
17. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
Nakagami H; Nada M
Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
[TBL] [Abstract][Full Text] [Related]
18. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
19. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
20. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
